UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Cannabidiol in patients with Lennox‐Gastaut syndrome: Interim analysis of an open‐label extension study

Epilepsia (Copenhagen), 2019-03, Vol.60 (3), p.419-428

2019

Volltextzugriff (PDF)

Long‐term safety and efficacy of add‐on cannabidiol in patients with Lennox–Gastaut syndrome: Results of a long‐term open‐label extension trial

Epilepsia (Copenhagen), 2021-09, Vol.62 (9), p.2228-2239

2021

Volltextzugriff (PDF)

Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial

The Lancet (British edition), 2018-03, Vol.391 (10125), p.1085-1096

2018

Volltextzugriff (PDF)

Adjunctive lacosamide for partial‐onset seizures: Efficacy and safety results from a randomized controlled trial

Epilepsia (Copenhagen), 2009-03, Vol.50 (3), p.443-453

2009

Volltextzugriff (PDF)

Time to onset of cannabidiol (CBD) treatment effect in Lennox–Gastaut syndrome: Analysis from two randomized controlled trials

Epilepsia (Copenhagen), 2021-05, Vol.62 (5), p.1130-1140

2021

Volltextzugriff (PDF)

Expanding the phenotype of DNAJC30‐associated Leigh syndrome

Clinical genetics, 2022-11, Vol.102 (5), p.438-443

2022

Volltextzugriff (PDF)

Recommendations for treatment strategies in people with epilepsy during times of shortage of antiseizure medications

Epileptic disorders, 2022-10, Vol.24 (5), p.751-764

2022

Volltextzugriff (PDF)

Next-generation sequencing testing in children with epilepsy reveals novel clinical, diagnostic and therapeutic implications

Frontiers in genetics, 2023, Vol.14, p.1300952-1300952

2023

Volltextzugriff (PDF)

Risdiplam-Treated Infants with Type 1 Spinal Muscular Atrophy versus Historical Controls

The New England journal of medicine, 2021-07, Vol.385 (5), p.427-435

2021

Volltextzugriff (PDF)

Evaluating the Credibility and Reliability of Online Information on Cannabidiol (CBD) for Epilepsy Treatment in Poland

Healthcare (Basel), 2024-04, Vol.12 (8), p.830

2024

Volltextzugriff (PDF)

Social Media as a Source of Knowledge about Gene Therapy for Spinal Muscular Atrophy

Healthcare (Basel), 2022-12, Vol.10 (12), p.2445

2022

Volltextzugriff (PDF)

Study of nusinersen metabolites in the cerebrospinal fluid of children with spinal muscular atrophy using ultra-high-performance liquid chromatography coupled with quadrupole-time-of-flight mass spectrometry

Analyst (London), 2024-07, Vol.149 (14), p.3739-3746

2024

Volltextzugriff (PDF)

A novel de novo FEM1C variant is linked to neurodevelopmental disorder with absent speech, pyramidal signs and limb ataxia

Human molecular genetics, 2023-03, Vol.32 (7), p.1152-1161

2023

Volltextzugriff (PDF)

The epilepsy phenotype of KCNK4-related neurodevelopmental disease

Seizure (London, England), 2024-10, Vol.121, p.114-122

2024

Volltextzugriff (PDF)

Managing CLN2 disease: a treatable neurodegenerative condition among other treatable early childhood epilepsies

Expert review of neurotherapeutics, 2021-11, Vol.21 (11), p.1275-1282

2021

Volltextzugriff (PDF)

Milestones in genetics of cerebellar ataxias

Neurogenetics, 2021-10, Vol.22 (4), p.225-234

2021

Volltextzugriff (PDF)

Delayed-Release Dimethyl Fumarate Safety and Efficacy in Pediatric Patients With Relapsing-Remitting Multiple Sclerosis

Frontiers in neurology, 2021-01, Vol.11, p.606418

2021

Volltextzugriff (PDF)

Nusinersen treatment of Spinal Muscular Atrophy Type 1 - results of expanded access programme in Poland

Neurologia i neurochirurgia polska, 2021-01, Vol.55 (3), p.289-294

2021

Volltextzugriff (PDF)

Cannabidiol in conjunction with clobazam: analysis of four randomized controlled trials

Acta neurologica Scandinavica, 2021-02, Vol.143 (2), p.154-163

2021

Volltextzugriff (PDF)

Development of the Method for Nusinersen and Its Metabolites Identification in the Serum Samples of Children Treated with Spinraza for Spinal Muscular Atrophy

International journal of molecular sciences, 2022-09, Vol.23 (17), p.10166

2022

Volltextzugriff (PDF)

Long-term adjunctive lacosamide treatment in patients with partial-onset seizures

Acta neurologica Scandinavica, 2016-02, Vol.133 (2), p.136-144

2016

Volltextzugriff (PDF)

Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome

The New England journal of medicine, 2017-05, Vol.376 (21), p.2011-2020

2017

Volltextzugriff (PDF)

Impairment of cognitive functions in children and adolescents with focal epilepsy

Heliyon, 2023-06, Vol.9 (6), p.e17210-e17210, Article e17210

2023

Volltextzugriff (PDF)

Improvement of serum sample preparation and chromatographic analysis of nusinersen used for the treatment of spinal muscular atrophy

Talanta (Oxford), 2024-01, Vol.267, p.125173-125173, Article 125173

2024

Volltextzugriff (PDF)

Epilepsy and cannabidiol: a guide to treatment

Epileptic disorders, 2020-02, Vol.22 (1), p.1-14

2020

Volltextzugriff (PDF)

1 – 25 von 100

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(89)
Mit Volltextzugriff
(60)

Publikationsform

Artikel
(100)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Cannabidiol in patients with Lennox‐Gastaut syndrome: Interim analysis of an open‐label extension study

Long‐term safety and efficacy of add‐on cannabidiol in patients with Lennox–Gastaut syndrome: Results of a long‐term open‐label extension trial

Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial

Adjunctive lacosamide for partial‐onset seizures: Efficacy and safety results from a randomized controlled trial

Time to onset of cannabidiol (CBD) treatment effect in Lennox–Gastaut syndrome: Analysis from two randomized controlled trials

Expanding the phenotype of DNAJC30‐associated Leigh syndrome

Recommendations for treatment strategies in people with epilepsy during times of shortage of antiseizure medications

Next-generation sequencing testing in children with epilepsy reveals novel clinical, diagnostic and therapeutic implications

Risdiplam-Treated Infants with Type 1 Spinal Muscular Atrophy versus Historical Controls

Evaluating the Credibility and Reliability of Online Information on Cannabidiol (CBD) for Epilepsy Treatment in Poland

Social Media as a Source of Knowledge about Gene Therapy for Spinal Muscular Atrophy

Study of nusinersen metabolites in the cerebrospinal fluid of children with spinal muscular atrophy using ultra-high-performance liquid chromatography coupled with quadrupole-time-of-flight mass spectrometry

A novel de novo FEM1C variant is linked to neurodevelopmental disorder with absent speech, pyramidal signs and limb ataxia

The epilepsy phenotype of KCNK4-related neurodevelopmental disease

Managing CLN2 disease: a treatable neurodegenerative condition among other treatable early childhood epilepsies

Milestones in genetics of cerebellar ataxias

Delayed-Release Dimethyl Fumarate Safety and Efficacy in Pediatric Patients With Relapsing-Remitting Multiple Sclerosis

Nusinersen treatment of Spinal Muscular Atrophy Type 1 - results of expanded access programme in Poland

Cannabidiol in conjunction with clobazam: analysis of four randomized controlled trials

Development of the Method for Nusinersen and Its Metabolites Identification in the Serum Samples of Children Treated with Spinraza for Spinal Muscular Atrophy

Long-term adjunctive lacosamide treatment in patients with partial-onset seizures

Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome

Impairment of cognitive functions in children and adolescents with focal epilepsy

Improvement of serum sample preparation and chromatographic analysis of nusinersen used for the treatment of spinal muscular atrophy

Epilepsy and cannabidiol: a guide to treatment

Suchergebnisse filtern